Abbrea Capital, LLC
- SEC CIK
- 0001697646
- Latest filing
- Aug 8, 2024
NVO holding history
Novo Nordisk A S in every 13F filed by Abbrea Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2024 holdings
- Shares (Q2 2024)
- 2,639
- Value
- $377.0K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 2,639 | $377.0K | <0.1% | −647−19.7% | Reduced | Holders |
| Q1 2024 | 3,286 | $425.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,286 | $340.0K | <0.1% | −150−4.4% | Reduced | Holders |
| Q3 2023 | 3,436 | $312.0K | <0.1% | +152+4.6% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 1,642 | $266.0K | <0.1% | −50−3.0% | Reduced | Holders |
| Q1 2023 | 1,692 | $271.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,692 | $229.0K | <0.1% | +1,692 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1,807−100.0% | Sold out | Holders |
| Q2 2022 | 1,807 | $201.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,807 | $203.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,807 | $202.0K | <0.1% | +1,807 | New | Holders |